HLA Web Resource for SNPs, Populations, Resources, ADRs, Diseases

Select Categories

Show Entries
Search:
PMID Allele Disease Population Drug Names SNP Class Sentence
29151323 HLA-CLASS I (HLA CLASS II) brucellosis NA NA NA unclassified
investigation of human leukocyte antigen in osteoarticular brucellosis background/aim: to determine the relationship between human leukocyte antigen (hla) antigens and osteoarticular brucellosis by evaluating hla class i and ii antigens in control subjects and patients developing osteoarticular brucellosis in turkey.materials and methods: the study included 28 patients with osteoarticular involvement diagnosed with brucellosis and 100 controls.
29151323 HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) brucellosis NA NA NA unclassified
investigation of human leukocyte antigen in osteoarticular brucellosis background/aim: to determine the relationship between human leukocyte antigen (hla) antigens and osteoarticular brucellosis by evaluating hla class i and ii antigens in control subjects and patients developing osteoarticular brucellosis in turkey.materials and methods: the study included 28 patients with osteoarticular involvement diagnosed with brucellosis and 100 controls.
29151323 HLA-CLASS I (HLA CLASS II) brucellosis NA NA NA unclassified
among the hla class i antigens, hla-cw*10 was determined in 35.71% of the patients and 17% of the controls; the difference was significant (p = 0.039).conclusion: in the development of brucellosis, the frequency of hla-cw*10 among hla class i antigens was observed to be increased, and hla-cw*10 was considered likely to cause predisposition to brucellosis.
25740878 HLA-B*13 molar pregnancies NA NA NA unclassified
manipulation of egfr signalling might thus offer a promising therapeutic avenue for the treatment of molar pregnancies associated with trophoblast hyperplasia.study funding/competing intereststhis study was supported by the austrian science fund (grant p-25187-b13 to j.p.).
25740878 HLA-B*13 hyperplasias NA NA NA unclassified
manipulation of egfr signalling might thus offer a promising therapeutic avenue for the treatment of molar pregnancies associated with trophoblast hyperplasia.study funding/competing intereststhis study was supported by the austrian science fund (grant p-25187-b13 to j.p.).
7763110 HLA-DRB1*04 bronchiectasis NA methacholine NA positive+negation
all five patients with bronchiectasis had the pi mm phenotype, four had hla-dr4, four had kcs and three achieved pc20 fev1; these values were not significantly different (p > 0.05) from those in patients without bronchiectasis.
9389220 HLA-DQA1*01 bronchiectasis NA NA NA unclassified
the patients with bronchiectasis were characterised by low values of fev1, fvc, fef25-75%, and tlco (p < 0.01), a high prevalence of small airways involvement (29% v 5%, p = 0.019), and a low prevalence of hla dqa1 *0501 allele (14% v 33%, p < 0.05).
16254274 HLA-C (HLA-C) bronchiectasis NA NA NA unclassified
hla-c and killer cell immunoglobulin-like receptor genes in idiopathic bronchiectasis.
16254274 HLA-CLASS I (HLA CLASS II) bronchiectasis NA NA NA unclassified
a possible role for natural killer (nk) cells is suggested by the observation that familial bronchiectasis occurs in a rare group of individuals with impaired hla class i expression and consequent nk cell dysfunction.
16254274 HLA-C (HLA-C) bronchiectasis NA NA NA unclassified
because the hla-c locus and killer cell immunoglobulin-like receptors (kirs) are of key importance for nk cell recognition, we analyzed hla-c/kir combinations by genotyping patients with idiopathic bronchiectasis.
CSIR logo Trisutra csir_logo

Copyright 2024